Patents by Inventor Jerry D. Childers
Jerry D. Childers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20030077320Abstract: A hydrocodone composition, a hydrocodone dosage form, and a method of administering hydrocodone are disclosed and indicated for hydrocodone therapy.Type: ApplicationFiled: December 18, 2002Publication date: April 24, 2003Inventors: Jerry D. Childers, George V. Guittard, Glen E. Barclay, Anthony L. Kuczynski, Patrick S.-L. Wong
-
Patent number: 6491945Abstract: A hydrocodone composition, a hydrocodone dosage form, and a method of administering hydrocodone are disclosed and indicated for hydrocodone therapy.Type: GrantFiled: September 16, 1994Date of Patent: December 10, 2002Assignee: ALZA CorporationInventors: Jerry D. Childers, George V. Guittard, Glen E. Barclay, Anthony L. Kuczynski, Patrick S. L. Wong
-
Patent number: 6036973Abstract: A dosage form is disclosed for administering 10 ng to 1200 mg tacrine to a patient in need of tacrine therapy.Type: GrantFiled: July 15, 1997Date of Patent: March 14, 2000Assignee: ALZA CorporationInventors: George V. Guittard, Jerry D. Childers, Patrick S.-L. Wong, Fernando E. Gumucio, David J. Kidney
-
Patent number: 5897878Abstract: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.Type: GrantFiled: October 21, 1992Date of Patent: April 27, 1999Assignee: ALZA CorporationInventors: Liang C. Dong, Michael H. Dealey, Terry L. Burkoth, Patrick S.-L. Wong, Jerry D. Childers, Brian L. Barclay
-
Patent number: 5869096Abstract: An osmotic device (10) for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device (10) comprises a wall (12) surrounding a compartment (13) housing a layer of an agent (14) that is insoluble to very soluble in aqueous biological fluids, e.g., saliva, and a layer (16) of a fluid swellable, hydrophilic polymer. A passageway (17) in the wall (12) connects the agent (14) with the exterior of the device (10). The wall (12) is permeable to the passage of aqueous biological fluid but substantially impermeable to the passage of the hydrophilic polymer (16). In one embodiment the beneficial agent (14) has a different color than the hydrophilic polymer (16). The wall (12) is sufficiently translucent to permit the patient to see the amount of drug/beneficial agent (14) remaining to be delivered.Type: GrantFiled: December 9, 1994Date of Patent: February 9, 1999Assignee: Alza CorporationInventors: Brian L. Barclay, Jerry D. Childers, Jeri Wright, Virgil A. Place, Patrick S. L. Wong
-
Patent number: 5866161Abstract: A hydrocodone composition, a hydrocodone dosage form, and a method of administering hydrocodone are disclosed and indicated for hydrocodone therapy.Type: GrantFiled: July 15, 1996Date of Patent: February 2, 1999Assignee: ALZA CorporationInventors: Jerry D. Childers, George V. Guittard, Glen E. Barclay, Anthony L. Kuczynski, Patrick S.-L. Wong
-
Patent number: 5866164Abstract: A composition of matter is disclosed and claimed comprising an opioid antagonist and a high molecular weight poly(alkylene) or a poly(carboxymethylcellulose). A dosage form is disclosed and claimed comprising the composition of matter for displacing an opioid analgesic from the dosage form.Type: GrantFiled: March 12, 1997Date of Patent: February 2, 1999Assignee: ALZA CorporationInventors: Anthony L. Kuczynski, Jerry D. Childers, Glen E. Barclay, Susan Rodriguez, Sonya Merrill
-
Patent number: 5842476Abstract: An osmotic device is disclosed comprising an exterior coat comprising an estrogenic and a progestogenic steroid that are delivered immediately as a contraceptive pair for fertility regulation in a female, and a compartment comprising an estrogenic steroid that is delivered at a controlled rate over a prolonged period of time for fertility regulation in a female.Type: GrantFiled: May 9, 1995Date of Patent: December 1, 1998Assignee: ALZA CorporationInventors: Jeri Dawn Wright, Jerry D. Childers, Brian L. Barclay, Patrick S.-L. Wong, Linda E. Atkinson
-
Patent number: 5830501Abstract: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.Type: GrantFiled: October 21, 1992Date of Patent: November 3, 1998Assignee: ALZA CorporationInventors: Liang C. Dong, Michael H. Dealey, Terry L. Burkoth, Patrick S. -L. Wong, Jerry D. Childers, Brian L. Barclay
-
Patent number: 5776493Abstract: An osmotic device (10) for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device (10) comprises a wall (12) surrounding a compartment (13) housing a layer of an agent (14) that is insoluble to very soluble in aqueous biological fluids, e.g., saliva, and a layer (16) of a fluid swellable, hydrophilic polymer. A passageway (17) in the wall (12) connects the agent (14) with the exterior of the device (10). The wall (12) is permeable to the passage of aqueous biological fluid but substantially impermeable to the passage of the hydrophilic polymer (16). In one embodiment the beneficial agent (14) has a different color than the hydrophilic polymer (16). The wall (12) is sufficiently translucent to permit the patient to see the amount of drug/beneficial agent (14) remaining to be delivered.Type: GrantFiled: December 22, 1993Date of Patent: July 7, 1998Assignee: ALZA CorporationInventors: Brian L. Barclay, Jerry D. Childers, Jeri Wright, Virgil A. Place, Patrick S.-L. Wong
-
Patent number: 5698224Abstract: A dosage form is disclosed for administering 10 ng to 1200 mg tacrine to a patient in need of tacrine therapy.Type: GrantFiled: June 27, 1994Date of Patent: December 16, 1997Assignee: Alza CorporationInventors: George V. Guittard, Jerry D. Childers, Patrick S. -L. Wong, Fernando E. Gumucio, David J. Kidney
-
Patent number: 5573776Abstract: An osmotic device (10) for delivering an ergot alkaloid into the mouth of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device (10) comprises a wall (12) surrounding a compartment (13) housing a layer of an ergot alkaloid (14) and a layer (16) of a fluid swellable, hydrophilic polymer. A passageway (17) in the wall (12) connects the ergot alkaloid (14) with the exterior of the device (10). The wall (12) is permeable to the passage of aqueous biological fluid but substantially impermeable to the passage of the hydrophilic polymer (16). In one embodiment the ergot alkaloid (14) has a different color than the hydrophilic polymer (16). The wall (12) is sufficiently translucent to permit the patient to see the amount of ergot alkaloid (14) remaining to be delivered.Type: GrantFiled: September 8, 1994Date of Patent: November 12, 1996Assignee: ALZA CorporationInventors: Juan M. E. Harrison, Brian L. Barclay, Jerry D. Childers, Jeri D. Wright, Virgil A. Place, Patrick S. Wong
-
Patent number: 5348746Abstract: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.Type: GrantFiled: October 21, 1992Date of Patent: September 20, 1994Assignee: Alza CorporationInventors: Liang C. Dong, Michael H. Dealey, Terry L. Burkoth, Patrick S. L. Wong, Jerry D. Childers, Brian L. Barclay
-
Patent number: 5266332Abstract: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.Type: GrantFiled: October 21, 1992Date of Patent: November 30, 1993Assignee: Alza CorporationInventors: Liang C. Dong, Michael H. Dealey, Terry L. Burkoth, Patrick S.-L. Wong, Jerry D. Childers, Brian L. Barclay
-
Patent number: 5254349Abstract: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.Type: GrantFiled: October 21, 1992Date of Patent: October 19, 1993Assignee: ALZA CorporationInventors: Liang C. Dong, Michael H. Dealey, Terry L. Burkoth, Patrick S. L. Wong, Jerry D. Childers, Brian L. Barclay
-
Patent number: 5248310Abstract: An osmotic device (10) for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device (10) comprises a wall (12) surrounding a compartment (13) housing a layer of an agent (14) that is insoluble to very soluble in aqueous biological fluids, e.g., saliva, and a layer (16) of a fluid swellable, hydrophilic polymer. A passageway (17) in the wall (12) connects the agent (14) with the exterior of the device (10). The wall (12) is permeable to the passage of aqueous biological fluid but substantially impermeable to the passage of the hydrophilic polymer (16). In one embodiment the beneficial agent (14) has a different color than the hydrophilic polymer (16). The wall (12) is sufficiently translucent to permit the patient to see the amount of drug/beneficial agent (14) remaining to be delivered.Type: GrantFiled: March 27, 1992Date of Patent: September 28, 1993Assignee: Alza CorporationInventors: Brian L. Barclay, Jerry D. Childers, Jeri D. Wright, Virgil A. Place, Patrick S.-L. Wong
-
Patent number: 5200195Abstract: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.Type: GrantFiled: December 6, 1991Date of Patent: April 6, 1993Assignee: ALZA CorporationInventors: Liang C. Dong, Michael H. Dealey, Terry L. Burkoth, Patrick S. L. Wong, Jerry D. Childers, Brian L. Barclay
-
Patent number: 5200197Abstract: An osmotic device is disclosed comprising an exterior coat comprising an estrogenic and a progestogenic steroid that are delivered immediately as a contraceptive pair for fertility regulation in a female, and a compartment comprising an estrogenic steroid that is delivered at a controlled rate over a prolonged period of time for fertility regulation in a female.Type: GrantFiled: December 9, 1991Date of Patent: April 6, 1993Assignee: Alza CorporationInventors: Jeri D. Wright, Jerry D. Childers, Brian L. Barclay, Patrick S.-L. Wong, Linda E. Atkinson
-
Patent number: 5147654Abstract: An osmotic device (10) for the controlled systemic delivery of nicotine through an oral mucosal membrane of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device (10) comprises a semipermeable wall (12) surrounding a compartment (13) containing a nicotine salt (14) and optionally an alkaline salt which is capable of reacting with the nicotine salt in the presence of water to form nicotine base. The conversion of nicotine salt to nicotine base may take place within the device (10) and/or outside the device and in the patient's mouth. Nicotine base and/or salt is delivered from the compartment (13) through a passageway (17) in the wall (12). The nicotine salt exhibits good stability and shelf life while the nicotine base exhibits excellent absorption through oral mucosal membranes.Type: GrantFiled: November 15, 1991Date of Patent: September 15, 1992Assignee: Alza CorporationInventors: Virgil A. Place, Patrick S. L. Wong, Brian L. Barclay, Jerry D. Childers
-
Patent number: 5098714Abstract: An osmotic device is disclosed comprising an exterior coat comprising an estrogenic and a progestogenic steroid that are delivered immediately as a contraceptive pair for fertility regulation in a female, and a compartment comprising an estrogenic steroid that is delivered at a controlled rate over a prolonged period of time for fertility regulation in a female.Type: GrantFiled: November 16, 1989Date of Patent: March 24, 1992Assignee: ALZA CorporationInventors: Jeri D. Wright, Jerry D. Childers, Brian L. Barclay, Patrick S. Wong, Linda E. Atkinson